(Q33193071)

English

CpG-A and B oligodeoxynucleotides enhance the efficacy of antibody therapy by activating different effector cell populations

scientific article published on September 1, 2003

Statements

CpG-A and B oligodeoxynucleotides enhance the efficacy of antibody therapy by activating different effector cell populations (English)

Identifiers

 
edit
    edit
      edit
        edit
          edit
            edit
              edit
                edit
                  edit